Experimental Hyperleptinemia Acutely Increases Vasoconstrictory Sympathetic Nerve Activity in Healthy Humans
The DOI matches its Crossref record; 20 of the 39 references it cites were found in a registry or an index.
Abstract
Background Obesity and arterial hypertension are tightly connected. Obese individuals show significant elevation of vasoconstrictory muscle sympathetic nerve activity (MSNA). Obesity-related hyperleptinemia might play a key role in mediating these effects. Leptin is synthesized in proportion to body fat mass and activates SNA in animal models. In humans, however, direct evidence linking hyperleptinemia to sympathetic activation has not yet been established. In the present study, we characterize the effects of acute hyperleptinemia on microneurographically recorded SNA in humans. Methods In a balanced, double-blind crossover design, 12 healthy normal-weight males received an iv bolus of leptin or placebo. MSNA (bursts per minute) was continuously recorded using a microneurographic technique. Ten-minute periods were analyzed at resting periods before (t-100) and at 20 (t20), 60 (t60), and 140 (t140) minutes after substance administration. Blood pressure and heart rate (HR) were recorded simultaneously. Results Baseline values of MSNA, blood pressure, and HR were comparable in both conditions (MSNA: t-100, 24.3 ± 1.6 vs 22.7 ± 1.7, not significant). After application of leptin, MSNA showed a significant increase (t20, 31.0 ± 1.9 vs. 24.9 ± 1.8, P = .05) that persisted until the end of the experiment (t60, P = .008; t140, P = .004). There were no significant changes in blood pressure and HR. Conclusions Acute experimental hyperleptinemia has significant central nervous excitatory…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to findings in rodents, acute leptin administration stimulates SNA in humans132.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [132]
In the citing paper
“More recent studies indicate that acute hyperleptinemia increases MSNA in humans85.”
From Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms (2015) · cites this paper as [85]
In the citing paper
“Acute leptin administration in rodents and humans increases renal and muscle SNS activity [45, 46] while chronic increases in plasma leptin levels, comparable to those found in severe obesity, caused sustained increases in BP and HR in rodents despite causing weight loss which would normally reduce BP [47].”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [46]
In the citing paper
“Machleidt et al93 demonstrated that a bolus injection of leptin in healthy lean men produced an acute increase in muscle sympathetic nerve activity but blood pressure did not increase.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [93]
In the citing paper
“They found that in young healthy man intravenous bolus administration of leptin caused a gradual increase in muscle sympathetic nerve activity that persisted for over 2 hours.”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [45]
Citations
Cites
Receptor-mediated regional sympathetic nerve activation by leptin.
Haynes, W. G., Morgan, D. A., Walsh, S. A., Mark, A. L., & Sivitz, W. I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119532 · Cited by 979
Ozata, M., Ozdemir, I. C., & Licinio, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.5999 · Cited by 739
Chronic Leptin Infusion Increases Arterial Pressure
Shek, E. W., Brands, M. W., & Hall, J. E. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.409 · Cited by 686
Modulation of Blood Pressure by Central Melanocortinergic Pathways
Greenfield, J. R., Miller, J. W., Keogh, J. M., Henning, E., Satterwhite, J. H., Cameron, G. S., Astruc, B., Mayer, J. P., Brage, S., See, T. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803085 · Cited by 477
Doll, S., Paccaud, F., Bovet, P., Burnier, M., & Wietlisbach, V (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801854 · Cited by 311
Renal Denervation Attenuates the Sodium Retention and Hypertension Associated With Obesity
Kassab, S., Kato, T., Wilkins, F. C., Chen, R., Hall, J. E., & Granger, J. P. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.893 · Cited by 307
Adrenergic and Reflex Abnormalities in Obesity-Related Hypertension
Grassi, G., Seravalle, G., Dell’Oro, R., Turri, C., Bolla, G. B., & Mancia, G. (2000) · Hypertension · doi:10.1161/01.hyp.36.4.538 · Cited by 305
Lambert, E. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00052 · Cited by 244
Role of leptin in blood pressure regulation and arterial hypertension
Bełtowski, J. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000222743.06584.66 · Cited by 215
Sympathetic nervous system behavior in human obesity
Davy, K. P., & Orr, J. S. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.05.024 · Cited by 166
Cited by
Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.305697 · Cited by 1,360
Obesity, kidney dysfunction and hypertension: mechanistic links
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654
The Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616
Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
Thorp, A. A., & Schlaich, M. P. (2015) · Journal of Diabetes Research · doi:10.1155/2015/341583 · Cited by 425
Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited
da Silva, A. A., do Carmo, J. M., Li, X., Wang, Z., Mouton, A. J., & Hall, J. E. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.02.066 · Cited by 368
Obesity, kidney dysfunction, and inflammation: interactions in hypertension
Hall, J. E., Mouton, A. J., da Silva, A. A., Omoto, A. C. M., Wang, Z., Li, X., & do Carmo, J. M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa336 · Cited by 265
Metabolic syndrome: a sympathetic disease?
Schlaich, M., Straznicky, N., Lambert, E., & Lambert, G. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70033-6 · Cited by 171
Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis
Rahmouni, K. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.00920 · Cited by 150
Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?
Lambert, É., Straznicky, N. E., Dixon, J. B., & Lambert, G. W. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00096.2015 · Cited by 124
Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases
Balasubramanian, P., Hall, D., & Subramanian, M. (2018) · GeroScience · doi:10.1007/s11357-018-0048-5 · Cited by 116
Long-Term Sympathoinhibitory Effects of Surgically Induced Weight Loss in Severe Obese Patients
Seravalle, G., Colombo, M., Perego, P., Giardini, V., Volpe, M., Dell’Oro, R., Mancia, G., & Grassi, G. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02988 · Cited by 80
“This allows to more directly and unequivocally document the evidence recently provided by a study showing the lower levels of MSNA in obese subjects 3 years after bariatric surgery compared with a control group.31 In our obese subjects, bariatric surgery was accompanied by a 6- and 12-month BP reduction (particularly…”
ResultInfluentialLeptin alters energy intake and fat mass but not energy expenditure in lean subjects
Chrysafi, P., Perakakis, N., Farr, O. M., Stefanakis, K., Peradze, N., Sala-Vila, A., & Mantzoros, C. S. (2020) · Nature Communications · doi:10.1038/s41467-020-18885-9 · Cited by 73
Obesity-Induced Hypertension: Brain Signaling Pathways
do Carmo, J. M., da Silva, A. A., Wang, Z., Fang, T., Aberdein, N., Rodriguez, C. E. P. D. L., & Hall, J. E. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0658-1 · Cited by 74
Webb, M. A., Davies, M. J., Ashra, N., Bodicoat, D. H., Brady, E. M., Webb, D. R., Moulton, C. D., Ismail, K., & Khunti, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187448 · Cited by 69
Obesity-induced increases in sympathetic nerve activity: Sex matters
Brooks, V. L., Shi, Z., Holwerda, S. W., & Fadel, P. J. (2014) · Autonomic Neuroscience · doi:10.1016/j.autneu.2014.11.006 · Cited by 64
“Leptin is well established as a sympathoexcitatory hormone in male animals and humans (Hall et al., 2010;Machleidt et al., 2013; Rahmouni, 2010).”
Saad, M. I., Abdelkhalek, T. M., Saleh, M. M., Kamel, M. A. E.-N., Youssef, M., Tawfik, S. H., & Domínguez, H. (2015) · Endocrine · doi:10.1007/s12020-015-0709-4 · Cited by 67
Obesity-Related Heart Failure with Preserved Ejection Fraction
Harada, T., & Obokata, M. (2020) · Heart Failure Clinics · doi:10.1016/j.hfc.2020.02.004 · Cited by 66
Sex differences in fat distribution influence the association between BMI and arterial stiffness
van den Munckhof, I., Holewijn, S., Graaf, J. D., & Rutten, J. H. W. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001297 · Cited by 58
Is the Brain a Key Player in Glucose Regulation and Development of Type 2 Diabetes?
Lundqvist, M., Almby, K. E., Abrahamsson, N., & Eriksson, J. W. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00457 · Cited by 60
“Evidence of ANS and HPA dysregulation in CNS and metabolic disorders are summarized in Table 1.”
BackgroundInfluentialRole of the brain melanocortins in blood pressure regulation
do Carmo, J. M., da Silva, A. A., Wang, Z., Fang, T., Aberdein, N., Perez de Lara, C. E., & Hall, J. E. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.03.003 · Cited by 38
“Acute leptin administration in rodents and humans increases renal and muscle SNS activity [45,46] while chronic increases in plasma leptin levels, comparable to those found in severe obesity, caused sustained increases in BP and HR in rodents despite causing weight loss which would normally reduce BP [47].”
Shi, Z., Wong, J., & Brooks, V. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00286-8 · Cited by 40
Control of respiratory and cardiovascular functions by leptin
Bassi, M., Furuya, W. I., Zoccal, D. B., Menani, J. V., Colombari, E., Hall, J. E., da Silva, A. A., do Carmo, J. M., & Colombari, D. S. A. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.01.019 · Cited by 39
“Acute hyperleptinemia also increases muscle SNA, as assessed by microneurography [54].”
Developmental Origins of Cardiometabolic Diseases: Role of the Maternal Diet
Costa‐Silva, J. H., Simões-Alves, A. C., & Fernandes, M. P. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00504 · Cited by 41
“…Volume 7 | Article 504 hyperleptinemia, common in overweight and obesity conditions, produce a misbalance in autonomic system, with sympathetic overactivation (Machleidt et al., 2013; Kurajoh et al., 2015; Manna and Jain, 2015), and reduced sensitivity of vagal afferent neurons (de Lartigue, 2016).”
BackgroundGijón‐Conde, T., Graciani, A., Guallar‐Castillón, P., Aguilera, M. T., Rodríguez‐Artalejo, F., & Banegas, J. R. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2014.08.015 · Cited by 40
“Tambie´n se ha estudiado la asociacio´n de la leptina con la hipertensio´n arterial (HTA) 6,7 , y se ha postulado que podrı´a activar el sistema nervioso simpa´tico y elevar la presio´n arterial 8,9 e incluso aumentar el riesgo de HTA 10–12 .”
BackgroundCentral mechanisms in sympathetic nervous dysregulation in obesity
Patel, M., Braun, J., Lambert, G. W., Kameneva, T., Keatch, C., & Lambert, É. (2023) · Journal of Neurophysiology · doi:10.1152/jn.00254.2023 · Cited by 38
de Faria, A. P., Ritter, A. M. V., Gasparetti, C. S., Corrêa, N. B., Brunelli, V., Almeida, A. R., Pires, N. F., Modolo, R., & Moreno, H. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190032 · Cited by 37
Leptin Is Not Essential for Obesity-Associated Hypertension
von Schnurbein, J., Manzoor, J., Brandt, S., Denzer, F., Kohlsdorf, K., Fischer‐Posovszky, P., Weißenberger, M., Frank, S., Mahmood, S., & Wabitsch, M. (2019) · Obesity Facts · doi:10.1159/000501319 · Cited by 27
Sex Differences in Leptin Control of Cardiovascular Function in Health and Metabolic Diseases
de Chantemèle, E. J. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_6 · Cited by 29
Straznicky, N. E., Grima, M. T., Sari, C. I., Lambert, É., Phillips, S. E., Eikelis, N., Mariani, J. A., Kobayashi, D., Hering, D., Dixon, J. B., et al. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00516 · Cited by 25
“Clinical leptin administration studies have yielded equivocal results (Mackintosh and Hirsch, 2001; Machleidt et al., 2013).”
BackgroundResultInfluentialHall, M. E., & Hall, J. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42973-3.00005-6 · Cited by 41
Ponnusamy, V., Owens, A. P., Purkayastha, S., Iodice, V., & Mathias, C. J. (2016) · Autonomic Neuroscience · doi:10.1016/j.autneu.2016.05.003 · Cited by 25
“There is a strong association, recently recognised, between JHS/EDS III and the postural tachycardia syndrome (PoTS) (Mathias et al, 2012).”
BackgroundInfluentialDuan, F., Wu, J., Chang, J., Peng, H., Liu, Z., Liu, P., Han, X., Sun, T., Shang, D., Yang, Y., et al. (2024) · Differentiation · doi:10.1016/j.diff.2024.100832 · Cited by 32
Tuuri, A., Jauhiainen, M., Tikkanen, M. J., & Kaaja, R. (2014) · Placenta · doi:10.1016/j.placenta.2014.07.016 · Cited by 20
“According to a current theory, adipocyte-derived hyperleptinemia could increase central sympathetic activity and lead to development of hypertension [21], and this could explain the increased risk of preeclampsia in obese women.”
BackgroundDoes leptin cause an increase in blood pressure in animals and humans?
Simonds, S. E., Pryor, J. T., & Cowley, M. A. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000287 · Cited by 21
Kim, L. J., Shin, M., Pho, H., Otvos, L. J., Tufik, S., Andersen, M. L., Pham, L. V., & Polotsky, V. Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.688375 · Cited by 16
Jemtel, T. H. L., Richardson, W., Samson, R., Jaiswal, A., & Oparil, S. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0713-6 · Cited by 15
Intranasal orexin A modulates sympathetic vascular tone: a pilot study in healthy male humans
Meusel, M., Voß, J., Krapalis, A. F., Machleidt, F., Vonthein, R., Hallschmid, M., & Sayk, F. (2022) · Journal of Neurophysiology · doi:10.1152/jn.00452.2021 · Cited by 14
Self-citationObasa, Z., van Vuuren, M., Huisamen, B., & Windvogel, S. L. (2021) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2020-048 · Cited by 13
Paleczny, B., Siennicka, A. E., Zacharski, M., Jankowska, E. A., Ponikowska, B., & Ponikowski, P. P. (2016) · Clinical Autonomic Research · doi:10.1007/s10286-015-0338-2 · Cited by 13
“[55] have shown that, in lean healthy men, acute intravenous infusion of leptin directly increases MSNA.”
BackgroundObesity and diabetes in heart disease in women
Fatade, Y. A., Dave, E. K., Vatsa, N., Crumbs, T., Calhoun, A. E., Sharma, A., SHUFELT, C. L., & Mehta, P. K. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2023.30 · Cited by 14
Gijón‐Conde, T., Graciani, A., Guallar‐Castillón, P., Aguilera, M. T., Rodríguez‐Artalejo, F., & Banegas, J. R. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.08.015 · Cited by 11
“En mujeres la mediana [intervalo intercuartı́lico] fue 24,5 [14,1-37,0] ng/ml y en varones, 7,2 [3,3-14,3] ng/ml.”
BackgroundSympathetic Inhibition After Bariatric Surgery
Mark, A. L., Norris, A. W., & Rahmouni, K. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03183 · Cited by 8
“A recent study of healthy lean men provided the first direct evidence that acute experimental hyperleptinemia increases muscle SNA in humans.(11) This supports the suggestion of Seravalle et al(2) that the pronounced decreases in muscle SNA after VSG may be mediated at least in part by the striking decreases in plasma…”
ResultObesity-Associated Hypertension: the Upcoming Phenotype in African-American Women
Samson, R., Qi, A., Jaiswal, A., Jemtel, T. H. L., & Oparil, S. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0738-x · Cited by 10
“Acute administration of leptin increases SNS activity in healthy humans without increasing BP due to offsetting nitric oxide mediated vasodilation [45, 46].”
Relation between waist circumference and the renal hemodynamic in healthy individuals
Bosch, A., Kannenkeril, D., Ott, C., Striepe, K., Schiffer, M., & Schmieder, R. E. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.10.033 · Cited by 3
Pathophysiology and Optimal Management of Hypertension in Patients with Cardiometabolic Syndrome
Ihm, S. (2021) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2021.1.e3 · Cited by 4
Sleep Deprivation, Endothelial Dysfunction and Hypertension: A Narrative Review
Yang, D., Ma, S., & Yu, Y. (2026) · Angiology · doi:10.1177/00033197261447021 · Cited by 1
Powiązanie otyłości ze zmianami w funkcjonowaniu mięśnia sercowego u zdrowych, młodych mężczyzn
Zalewski, P., Bitner, A., Frith, J., Siński, M., Pawlak, J., Klawe, J. J., Tafil‐Klawe, M., & Newton, J. L. (2016) · Folia Cardiologica · doi:10.5603/fc.2016.0027 · Cited by 1
Autonomic Nervous System: Metabolic Function☆
Straznicky, N. E., Lambert, É., Lambert, G. W., & Esler, M. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.01819-8 · Cited by 1
Leptin, the Autonomic Nervous System, and Hypertension
da Silva, A. A., do Carmo, J. M., Wang, Z., & Hall, J. E. (2014) · Springer eBooks · doi:10.1007/978-3-319-09915-6_14 · Cited by 1
Tuuri, A. (2014) · Helda - University of Helsinki Institutional Repository · Cited by 1
The role of leptin in endothelial dysfunction and cardiovascular disease
García, G. M., & Cruz, M. O. (2013) · Cited by 1
Machleidt, F., Ott, V., & Lehnert, H. (2013) · Der Diabetologe · doi:10.1007/s11428-013-1061-z
Self-citationYlipainon aiheuttamat muutokset hemodynamiikan säätelyssä
Ketola, I. (2016) · Tampere University Institutional Repository (Tampere University)
Metabolisches Syndrom: Prävention und Therapie
Schmid, S. M. (2016) · Springer eBooks · doi:10.1007/978-3-642-54676-1_2-1
Chi, Z.-C. (2022) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v30.i11.465
Pakmehr, A., Hezaveh, Z. S., Fakhrzadeh, H., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2824131/v1
Vasomotor and fibrinolytic effects of leptin in man
Gonzalez, M. A., Robinson, S. D., Mills, N. L., Eriksson, M., Sandström, T., Newby, D. E., Olsson, T., Blomberg, A., & Söderberg, S. (2025) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2025.2478867
“Furthermore, Machleidt et al. showed that vasoconstrictor muscle sympathetic nerve activity in healthy men increased within 20 min after an intravenous bolus of leptin without any effects on blood pressure and heart rate [34].”
Etude de la contribution de l'hormone adipocytaire leptine dans la pathogenèse du syndrome de Rett
Belaïdouni, Y. (2022) · theses.fr (ABES) · doi:10.70675/f69d2875zfa9fz4465z917eza8e7b93935c6
Pakmehr, A., Hezaveh, Z. S., Fakhrzadeh, H., Moodi, M., Khorashadizadeh, M., Marvasti, F. E., Taghavi, M., Ejtahed, H., & Sharifi, F. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01955-y
Cardiometabolic regulation by adipocyte-derived leptin and the brain melanocortin system
Hall, J. E., Omoto, A. C. M., do Carmo, J. M., da Silva, A. A., Mouton, A. J., Wang, Z., & Hall, M. E. (2026) · Clinical Science · doi:10.1042/cs20250039
Zhu, C., Ding, Y., Chen, L., et al. (2026) · Archives of Public Health · doi:10.1186/s13690-026-02008-9
“Nevertheless, the association between obesity and hypertension and its associated mechanisms has been documented across pediatric and adult populations [61, 62].”
Metadata
- Authors
- Machleidt, F., Simon, P., Krapalis, A. F., Hallschmid, M., Lehnert, H., & Sayk, F.
- Affiliations
- University Hospital Schleswig-Holstein (DE)
- University of Tübingen (DE)
- Corresponding author
- Sayk, Friedhelm
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-03-01
- Volume
- 98
- Issue
- 3
- Pages
- E491-E496
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2105572243
- Cited by
- 61
- References
- 39
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 1 · 2017: 7 · 2016: 10 · 2015: 8 · 2014: 8 · 2013: 2
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Keywords
- leptin, hyperleptinemia, muscle sympathetic nerve activity, vasoconstriction, sympathetic nervous system, obesity, hypertension, blood pressure, heart rate, microneurography, central nervous system stimulation
- MeSH terms
- Acute Disease, Adult, Blood Pressure, Double-Blind Method, Heart Rate, Humans, Hypertension, Injections, Intravenous, Male, Obesity, Pressoreceptors, Sympathetic Nervous System, Vasoconstriction, Muscle, Skeletal, Cross-Over Studies, Leptin, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.